FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2057674977> ?p ?o ?g. }

• W2057674977 endingPage "587" @default.
• W2057674977 startingPage "582" @default.
• W2057674977 abstract "The objective of this multicenter, randomized, open-label, parallel-group, 8-week study was to evaluate the comparative dose efficacy of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor atorvastatin 10, 20, 40, and 80 mg compared with simvastatin 10, 20, and 40 mg, pravastatin 10, 20, and 40 mg, lovastatin 20, 40, and 80 mg, and fluvastatin 20 and 40 mg. Investigators enrolled 534 hypercholesterolemic patients (low-density lipoprotein [LDL] cholesterol ≥160 mg/dl [4.2 mmol/L] and triglycerides ≤400 mg/dl [4.5 mmol/L]). The efficacy end points were mean percent change in plasma LDL cholesterol (primary), total cholesterol, triglycerides, and high-density lipoprotein cholesterol concentrations from baseline to the end of treatment (week 8). Atorvastatin 10, 20, and 40 mg produced greater (p ≤0.01) reductions in LDL cholesterol, −38%, −46%, and −51%, respectively, than the milligram equivalent doses of simvastatin, pravastatin, lovastatin, and fluvastatin. Atorvastatin 10 mg produced LDL cholesterol reductions comparable to or greater than (p ≤0.02) simvastatin 10, 20, and 40 mg, pravastatin 10, 20, and 40 mg, lovastatin 20 and 40 mg, and fluvastatin 20 and 40 mg. Atorvastatin 10, 20, and 40 mg produced greater (p ≤0.01) reductions in total cholesterol than the milligram equivalent doses of simvastatin, pravastatin, lovastatin, and fluvastatin. All reductase inhibitors studied had similar tolerability. There were no incidences of persistent elevations in serum transaminases or myositis." @default.
• W2057674977 created "2016-06-24" @default.
• W2057674977 creator A5010300943 @default.
• W2057674977 creator A5053195722 @default.
• W2057674977 creator A5088270258 @default.
• W2057674977 creator A5091215222 @default.
• W2057674977 date "1998-03-01" @default.
• W2057674977 modified "2023-10-18" @default.
• W2057674977 title "Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997." @default.
• W2057674977 cites W138462898 @default.
• W2057674977 cites W1514980419 @default.
• W2057674977 cites W1520236889 @default.
• W2057674977 cites W1832817057 @default.
• W2057674977 cites W1966330620 @default.
• W2057674977 cites W2004746082 @default.
• W2057674977 cites W2008936746 @default.
• W2057674977 cites W2012757283 @default.
• W2057674977 cites W2026888128 @default.
• W2057674977 cites W2046524469 @default.
• W2057674977 cites W2059347401 @default.
• W2057674977 cites W2069303130 @default.
• W2057674977 cites W2083183642 @default.
• W2057674977 cites W2103851590 @default.
• W2057674977 cites W2104620118 @default.
• W2057674977 cites W2106536809 @default.
• W2057674977 cites W2106890766 @default.
• W2057674977 cites W2116404316 @default.
• W2057674977 cites W2118310760 @default.
• W2057674977 cites W2160760242 @default.
• W2057674977 cites W3098834270 @default.
• W2057674977 cites W4240553663 @default.
• W2057674977 cites W81463456 @default.
• W2057674977 cites W847116411 @default.
• W2057674977 doi "https://doi.org/10.1016/s0002-9149(97)00965-x" @default.
• W2057674977 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9514454" @default.
• W2057674977 hasPublicationYear "1998" @default.
• W2057674977 type Work @default.
• W2057674977 sameAs 2057674977 @default.
• W2057674977 citedByCount "1027" @default.
• W2057674977 countsByYear W20576749772012 @default.
• W2057674977 countsByYear W20576749772013 @default.
• W2057674977 countsByYear W20576749772014 @default.
• W2057674977 countsByYear W20576749772015 @default.
• W2057674977 countsByYear W20576749772016 @default.
• W2057674977 countsByYear W20576749772017 @default.
• W2057674977 countsByYear W20576749772018 @default.
• W2057674977 countsByYear W20576749772019 @default.
• W2057674977 countsByYear W20576749772020 @default.
• W2057674977 countsByYear W20576749772021 @default.
• W2057674977 countsByYear W20576749772022 @default.
• W2057674977 countsByYear W20576749772023 @default.
• W2057674977 crossrefType "journal-article" @default.
• W2057674977 hasAuthorship W2057674977A5010300943 @default.
• W2057674977 hasAuthorship W2057674977A5053195722 @default.
• W2057674977 hasAuthorship W2057674977A5088270258 @default.
• W2057674977 hasAuthorship W2057674977A5091215222 @default.
• W2057674977 hasConcept C104950815 @default.
• W2057674977 hasConcept C126322002 @default.
• W2057674977 hasConcept C126894567 @default.
• W2057674977 hasConcept C134018914 @default.
• W2057674977 hasConcept C134651460 @default.
• W2057674977 hasConcept C181199279 @default.
• W2057674977 hasConcept C185592680 @default.
• W2057674977 hasConcept C197934379 @default.
• W2057674977 hasConcept C2776329913 @default.
• W2057674977 hasConcept C2776839432 @default.
• W2057674977 hasConcept C2777320049 @default.
• W2057674977 hasConcept C2777482532 @default.
• W2057674977 hasConcept C2778163477 @default.
• W2057674977 hasConcept C2778375690 @default.
• W2057674977 hasConcept C2778417548 @default.
• W2057674977 hasConcept C2779519902 @default.
• W2057674977 hasConcept C2780940807 @default.
• W2057674977 hasConcept C55493867 @default.
• W2057674977 hasConcept C71924100 @default.
• W2057674977 hasConcept C98274493 @default.
• W2057674977 hasConceptScore W2057674977C104950815 @default.
• W2057674977 hasConceptScore W2057674977C126322002 @default.
• W2057674977 hasConceptScore W2057674977C126894567 @default.
• W2057674977 hasConceptScore W2057674977C134018914 @default.
• W2057674977 hasConceptScore W2057674977C134651460 @default.
• W2057674977 hasConceptScore W2057674977C181199279 @default.
• W2057674977 hasConceptScore W2057674977C185592680 @default.
• W2057674977 hasConceptScore W2057674977C197934379 @default.
• W2057674977 hasConceptScore W2057674977C2776329913 @default.
• W2057674977 hasConceptScore W2057674977C2776839432 @default.
• W2057674977 hasConceptScore W2057674977C2777320049 @default.
• W2057674977 hasConceptScore W2057674977C2777482532 @default.
• W2057674977 hasConceptScore W2057674977C2778163477 @default.
• W2057674977 hasConceptScore W2057674977C2778375690 @default.
• W2057674977 hasConceptScore W2057674977C2778417548 @default.
• W2057674977 hasConceptScore W2057674977C2779519902 @default.
• W2057674977 hasConceptScore W2057674977C2780940807 @default.
• W2057674977 hasConceptScore W2057674977C55493867 @default.
• W2057674977 hasConceptScore W2057674977C71924100 @default.
• W2057674977 hasConceptScore W2057674977C98274493 @default.
• W2057674977 hasIssue "5" @default.
• W2057674977 hasLocation W20576749771 @default.

• next